Inhaled corticosteroid improved the perception of dyspnea during methacholine induced bronchoconstriction and changed the hypoxic ventilatory response in patients with asthma
S. Shiraishi, K. Hirata, K. Ohtani, K. Asai, J. Yoshikawa (Osaka, Japan)
Source: Annual Congress 2002 - Asthma: Inflammation, hyperreactivity, treatment side effects
Disease area: Airway diseases
Abstract [Background] An important endogenous factor that contributes to the development of frequent exacerbations in asthma is a diminished perception of breathlessness. It is not well known that inhaled corticosteroid improve the perception of bronchoconstriction and hypoxia in asthma. [Methods] We studied 36 patients with mild asthma (17 male and 19 female, mean age 39.2 yr). They were allocated to the use of either a short-acting beta-2 agonist (salbutamol, n=18: beta group) or an inhaled corticosteroid (fluticasone, n=18: ICS group). We examined the methacholine challenge test and hypoxic ventilatory response (HOVR). In HOVR, we recorded minute ventilation (VE) and the mouth occulusion pressure at 100 msec of inspiration (P 0.1). The severity of dyspnea during the methacholine challenge test and during hypoxia was assessed by a Borg score. Borg scores of all subjects were plotted against percentage of fall in FEV1 from baseline and fall in SpO2 from baseline. Individual Borg/FEV1 slopes (Slope-Borg Mch) and Borg/SpO2 slopes (Slope-Borg HOVR), representing an index of dyspnea, were calculated by liner regression analysis for Mch challenges and HOVR. [Results] In the ICS group, P 0.1 showed significantly lower level than beta group (p=0.046), and the slope-Borg Mch showed higher level than beta group (p=0.0019). The Slope-Borg HOVR did not differ significantly between the beta group and the ICS group. [Conclusion] Inhaled corticosteroid may improve the perception of bronchoconstriction, and changed the HOVR.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Shiraishi, K. Hirata, K. Ohtani, K. Asai, J. Yoshikawa (Osaka, Japan). Inhaled corticosteroid improved the perception of dyspnea during methacholine induced bronchoconstriction and changed the hypoxic ventilatory response in patients with asthma. Eur Respir J 2002; 20: Suppl. 38, 422
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Inhaled corticosteroids decrease cough reflex sensitivity to capsaicin in asthmatics but not in patients with COPD Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008
Bronchodilator response following methacholine-induced bronchoconstriction predicts acute asthma exacerbations Source: Eur Respir J 2016; 48: 104-114 Year: 2016
Hypertonic histamine challenge induced cough in assessing the treatment response to inhaled corticosteroid in asthma Source: Annual Congress 2008 - Cough and airway hyperresponsiveness Year: 2008
Assessment of bronchial hyperreactivity, maximal airway response and response to inhaled corticosteriod treatment in patients with bronchiectasis Source: Annual Congress 2007 - Current issues in airway physiology, pharmacology and monitoring Year: 2007
The perception of breathlessness during bronchoconstriction induced by mannitol in COPD Source: Annual Congress 2008 - Investigation, inspiration, ventilation, dedication: the essence of physiological measurement Year: 2008
Subjects in clinical remission of atopic asthma show normal dyspnoea perception during methacholine and adenosine induced bronchoconstriction Source: Eur Respir J 2001; 18: Suppl. 33, 46s Year: 2001
Bronchodilator responsiveness following methacholine-induced bronchoconstriction in children with clinically highly suspected asthma Source: Annual Congress 2012 - Predicting and observing paediatric allergic disease Year: 2012
The language of dyspnoea during exercise and induced bronchoconstriction in asthmatics Source: Eur Respir J 2004; 24: Suppl. 48, 338s Year: 2004
sGaw as an alternative for FEV1 in the measurement of airway responsiveness to methacholine in patients experiencing chronic cough Source: Annual Congress 2011 - Lung function today and tomorrow I Year: 2011
Changes in the pattern of breathing and dyspnoea sensation during methacholine-induced bronchoconstriction in asthmatic patients Source: Eur Respir J 2001; 18: Suppl. 33, 86s Year: 2001
Exercise induced bronchoconstriction and dyspnoea in asthmatic children Source: Annual Congress 2011 - Advances in lung function testing from infancy to adulthood Year: 2011
Influence of a low dose of BDP-HFA on methacholine or exercise-induced lung hyperinflation in mild asthma Source: Eur Respir J 2005; 26: Suppl. 49, 508s Year: 2005
Bronchodilator efficacy and bronchial responsiveness in patients with bronchodilator-responsive chronic cough Source: Annual Congress 2009 - Accuracy in lung function testing Year: 2009
Bronchodilator efficacy and bronchial responsiveness in patients with bronchodilator-responsive chronic cough Source: Annual Congress 2006 - Established and experimental therapies for allergic asthma Year: 2006
Bronchial responsiveness and chronic non-productive cough responding to bronchodilator therapy Source: Annual Congress 2008 - Lung function, airways and cough Year: 2008
Bronchial hyperresponsiveness to methacholine/AMP and the bronchodilator response in asthmatic children Source: Eur Respir J 2011; 37: 800-805 Year: 2011
The perception of dyspnea during exercise-induced bronchoconstriction in asthmatic children Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools Year: 2018
Bronchial hypersensitivity and acute bronchodilatory effect of salbutamol on methacholine-induced bronchoconstriction in asthmatics with excessive airway narrowing Source: Eur Respir J 2004; 24: Suppl. 48, 442s Year: 2004
Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: Eur Respir J 2017; 49(1): 1600839; DOI: 10.1183/13993003.00839-2016 Year: 2017
Airway inflammation in COPD after long-term withdrawal of inhaled corticosteroids Source: Eur Respir J, 49 (6) 1700848; 10.1183/13993003.00848-2017 Year: 2017